Immunosuppressant compound
US4981792A · kind A · utility
23Cited by
1References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 29, 1988 |
| Grant date | Jan 1, 1991 |
| Priority date | — |
| Expiry date | Jun 29, 2008 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/827
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Described is a process for producing a new immunosuppressant, "demethomycin" (L-682,993) a C-31 demethylated analog of L-679,934 under novel fermentation conditions utilizing the microorganism, Actinoplanacete sp., (Merck Culture Collection MA 6559) ATCC No. 53771. The macrolide immunosuppressant is useful in prevent human host rejection of foreign organ transplants, e.g. bone marrow and heart transplants.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.